These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14638885)

  • 21. Pyridostigmine in the treatment of orthostatic intolerance.
    Gales BJ; Gales MA
    Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience.
    Kanjwal K; Karabin B; Sheikh M; Elmer L; Kanjwal Y; Saeed B; Grubb BP
    Pacing Clin Electrophysiol; 2011 Jun; 34(6):750-5. PubMed ID: 21410722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome.
    Bertolasi L; Frasson E; Turri M; Gajofatto A; Bordignon M; Zanolin E; Martini M; Pimazzoni F; Ferlisi M; Zanusso G; Rossi M; Monaco S
    J Neurol Sci; 2013 Jul; 330(1-2):94-9. PubMed ID: 23683859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis.
    De Feo LG; Schottlender J; Martelli NA; Molfino NA
    Muscle Nerve; 2002 Jul; 26(1):31-6. PubMed ID: 12115946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-polio syndrome: Pathophysiological hypotheses, diagnosis criteria, drug therapy.
    Boyer FC; Tiffreau V; Rapin A; Laffont I; Percebois-Macadré L; Supper C; Novella JL; Yelnik AP
    Ann Phys Rehabil Med; 2010 Feb; 53(1):34-41. PubMed ID: 20093102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle adaptation and disability in late poliomyelitis.
    Einarsson G
    Scand J Rehabil Med Suppl; 1991; 25():1-76. PubMed ID: 1838429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term effects of aerobic exercise on functional capacity, fatigue, and quality of life in patients with post-polio syndrome.
    Oncu J; Durmaz B; Karapolat H
    Clin Rehabil; 2009 Feb; 23(2):155-63. PubMed ID: 19164403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relief from episodic weakness with pyridostigmine in paramyotonia congenita: a family study.
    Khadilkar SV; Singh RK; Mansukhani KA; Urtizberea JA; Sternberg D
    Muscle Nerve; 2010 Jan; 41(1):133-7. PubMed ID: 19768756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subjective recovery time after exhausting muscular activity in postpolio and control subjects.
    Agre JC; Rodriquez AA; Franke TM
    Am J Phys Med Rehabil; 1998; 77(2):140-4. PubMed ID: 9558015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of repeated doses of 30 mg pyridostigmine bromide on pilot performance in an A-4 flight simulator.
    Izraeli S; Avgar D; Almog S; Shochat I; Tochner Z; Tamir A; Ribak J
    Aviat Space Environ Med; 1990 May; 61(5):430-2. PubMed ID: 2190549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combination of 6 months of treatment with pyridostigmine and triweekly exercise fails to improve insulin-like growth factor-I levels in fibromyalgia, despite improvement in the acute growth hormone response to exercise.
    Jones KD; Deodhar AA; Burckhardt CS; Perrin NA; Hanson GC; Bennett RM
    J Rheumatol; 2007 May; 34(5):1103-11. PubMed ID: 17407215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced low-threshold motor unit capacity during endurance tasks in patients with spinal muscular atrophy using pyridostigmine.
    Habets LE; Bartels B; Jeneson JAL; Asselman FL; Stam M; Wijngaarde CA; Wadman RI; van Eijk RPA; Stegeman DF; Ludo van der Pol W
    Clin Neurophysiol; 2023 Oct; 154():100-106. PubMed ID: 37595479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle strength in postpolio patients: a prospective follow-up study.
    Ivanyi B; Nelemans PJ; de Jongh R; Ongerboer de Visser BW; de Visser M
    Muscle Nerve; 1996 Jun; 19(6):738-42. PubMed ID: 8609924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study.
    Farbu E; Rekand T; Vik-Mo E; Lygren H; Gilhus NE; Aarli JA
    Eur J Neurol; 2007 Jan; 14(1):60-5. PubMed ID: 17222115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent isometric activity: its effect on muscle fatigue in postpolio subjects.
    Agre JC; Rodriquez AA
    Arch Phys Med Rehabil; 1991 Nov; 72(12):971-5. PubMed ID: 1953320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presynaptic neuromuscular transmission defect in the stiff person syndrome.
    Lo YL; Tan YE
    BMC Neurol; 2016 Dec; 16(1):249. PubMed ID: 27905901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immunoglobulin for postpolio syndrome: a systematic review and meta-analysis.
    Huang YH; Chen HC; Huang KW; Chen PC; Hu CJ; Tsai CP; Tam KW; Kuan YC
    BMC Neurol; 2015 Mar; 15():39. PubMed ID: 25886512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.
    Behling A; Moraes RS; Rohde LE; Ferlin EL; Nóbrega AC; Ribeiro JP
    Am Heart J; 2003 Sep; 146(3):494-500. PubMed ID: 12947369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatigue in postpolio syndrome.
    Berlly MH; Strauser WW; Hall KM
    Arch Phys Med Rehabil; 1991 Feb; 72(2):115-8. PubMed ID: 1991011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome.
    Stein DP; Dambrosia JM; Dalakas MC
    Ann N Y Acad Sci; 1995 May; 753():296-302. PubMed ID: 7611638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.